Glen Eagle Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $66.2K | Sell |
126
-10
| -7% | -$5.25K | 0.01% | 377 |
|
2025
Q1 | $86.3K | Hold |
136
| – | – | 0.01% | 328 |
|
2024
Q4 | $96.9K | Hold |
136
| – | – | 0.02% | 311 |
|
2024
Q3 | $143K | Hold |
136
| – | – | 0.02% | 275 |
|
2024
Q2 | $143K | Buy |
136
+10
| +8% | +$10.5K | 0.03% | 263 |
|
2024
Q1 | $121K | Sell |
126
-2
| -2% | -$1.93K | 0.02% | 284 |
|
2023
Q4 | $112K | Hold |
128
| – | – | 0.02% | 284 |
|
2023
Q3 | $105K | Hold |
128
| – | – | 0.02% | 286 |
|
2023
Q2 | $92K | Hold |
128
| – | – | 0.02% | 298 |
|
2023
Q1 | $105K | Sell |
128
-1
| -0.8% | -$822 | 0.03% | 278 |
|
2022
Q4 | $93.1K | Buy |
129
+1
| +0.8% | +$721 | 0.03% | 286 |
|
2022
Q3 | $88.2K | Sell |
128
-8
| -6% | -$5.51K | 0.03% | 278 |
|
2022
Q2 | $80.4K | Hold |
136
| – | – | 0.02% | 305 |
|
2022
Q1 | $95K | Hold |
136
| – | – | 0.02% | 288 |
|
2021
Q4 | $85.9K | Hold |
136
| – | – | 0.02% | 301 |
|
2021
Q3 | $82.3K | Sell |
136
-5
| -4% | -$3.03K | 0.02% | 300 |
|
2021
Q2 | $78.8K | Sell |
141
-60
| -30% | -$33.5K | 0.02% | 303 |
|
2021
Q1 | $95.1K | Sell |
201
-50
| -20% | -$23.7K | 0.03% | 258 |
|
2020
Q4 | $121K | Sell |
251
-9
| -3% | -$4.35K | 0.05% | 213 |
|
2020
Q3 | $146K | Hold |
260
| – | – | 0.07% | 183 |
|
2020
Q2 | $162K | Buy |
260
+108
| +71% | +$67.4K | 0.08% | 167 |
|
2020
Q1 | $74.2K | Buy |
152
+107
| +238% | +$52.2K | 0.05% | 223 |
|
2019
Q4 | $16.9K | Hold |
45
| – | – | 0.01% | 491 |
|
2019
Q3 | $12.5K | Hold |
45
| – | – | 0.01% | 475 |
|
2019
Q2 | $14.1K | Hold |
45
| – | – | 0.01% | 450 |
|
2019
Q1 | $18.5K | Hold |
45
| – | – | 0.01% | 394 |
|
2018
Q4 | $16.8K | Hold |
45
| – | – | 0.01% | 386 |
|
2018
Q3 | $18.2K | Hold |
45
| – | – | 0.01% | 392 |
|
2018
Q2 | $15.5K | Hold |
45
| – | – | 0.01% | 394 |
|
2018
Q1 | $15.5K | Hold |
45
| – | – | 0.01% | 373 |
|
2017
Q4 | $16.9K | Hold |
45
| – | – | 0.01% | 359 |
|
2017
Q3 | $20.1K | Hold |
45
| – | – | 0.02% | 334 |
|
2017
Q2 | $22.1K | Hold |
45
| – | – | 0.02% | 298 |
|
2017
Q1 | $17.4K | Hold |
45
| – | – | 0.01% | 301 |
|
2016
Q4 | $16.5K | Buy |
+45
| New | +$16.5K | 0.01% | 292 |
|